Q: What is Iovance Biotherapeutics, Inc. Common Stock's WACC?

Iovance Biotherapeutics, Inc. Common Stock (IOVA) has a Weighted Average Cost of Capital (WACC) of 10.17%. This is calculated using a Cost of Equity of 10.18% (via CAPM with a beta of 1.47) and a pre-tax Cost of Debt of 2.00%, with an equity weight of 99.94% in the capital structure.

Q: Is Iovance Biotherapeutics, Inc. Common Stock's WACC high or low?

Iovance Biotherapeutics, Inc. Common Stock's WACC of 10.17% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Q: How is Iovance Biotherapeutics, Inc. Common Stock's WACC calculated?

Iovance Biotherapeutics, Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 10.18% is derived from the CAPM model using a beta of 1.47. The pre-tax Cost of Debt (Rd) is 2.00%. The capital structure is 99.94% equity and 0.06% debt.

Question 1

What is Iovance Biotherapeutics, Inc. Common Stock's WACC?

Accepted Answer

Iovance Biotherapeutics, Inc. Common Stock（IOVA） WACC 解读

Iovance Biotherapeutics, Inc. Common Stock（IOVA）当前估算的 WACC 为 10.17%。其中股权成本为 10.18%，税前债务成本为 2.00%，股权权重为 99.94%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于常见区间，适合作为成熟公司 DCF 假设的基准参考。

Question 2

Is Iovance Biotherapeutics, Inc. Common Stock's WACC high or low?

Accepted Answer

Iovance Biotherapeutics, Inc. Common Stock（IOVA） WACC 解读

Iovance Biotherapeutics, Inc. Common Stock（IOVA）当前估算的 WACC 为 10.17%。其中股权成本为 10.18%，税前债务成本为 2.00%，股权权重为 99.94%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于常见区间，适合作为成熟公司 DCF 假设的基准参考。

Question 3

How is Iovance Biotherapeutics, Inc. Common Stock's WACC calculated?

Accepted Answer

Iovance Biotherapeutics, Inc. Common Stock（IOVA） WACC 解读

Iovance Biotherapeutics, Inc. Common Stock（IOVA）当前估算的 WACC 为 10.17%。其中股权成本为 10.18%，税前债务成本为 2.00%，股权权重为 99.94%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于常见区间，适合作为成熟公司 DCF 假设的基准参考。

Iovance Biotherapeutics, Inc. Common Stock (IOVA) — WACC 分析

WACC 构成

解读

Iovance Biotherapeutics, Inc. Common Stock（IOVA）WACC：10.17%

WACC计算器

Iovance Biotherapeutics, Inc. Common Stock（IOVA） WACC 解读

IOVA 公司分析

IOVA DCF 估值

继续做同行对比